Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Neuropathology ; 34(1): 49-57, 2014 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-23711246

RESUMO

Niemann-Pick disease type C (NPC) is an autosomal recessive neurovisceral lipid storage disorder. Two disease-causing genes (NPC1 and NPC2) have been identified. NPC is characterized by neuronal and glial lipid storage and NFTs. Here, we report a man with juvenile-onset progressive neurological deficits, including pyramidal signs, ataxia, bulbar palsy, vertical supranuclear ophthalmoplegia, and psychiatric symptoms; death occurred at age 37 before definitive clinical diagnosis. Post mortem gross examination revealed a unique distribution of brain atrophy, predominantly in the frontal and temporal lobes. Microscopically, lipid storage in neurons and widely distributed NFTs were observed. Lipid storage cells appeared in systemic organs and filipin staining indicated intracellular cholesterol accumulation in hepatic macrophages. Electron microscopy revealed accumulation of lipids and characteristic oligolamellar inclusions. These findings suggested an NPC diagnosis. Neuronal loss and gliosis were frequently accompanied by NFTs and occurred in the frontal and temporal cortices, hippocampus, amygdala, basal forebrain, basal ganglia, thalamus, substantia nigra and brain stem nuclei. Lewy bodies (LBs) were observed in most, but not all, regions where NFTs were evident. In contrast, neuronal lipid storage occurred in more widespread areas, including the parietal and occipital cortices where neurodegeneration with either NFTs or LBs was minimal. Molecular genetic analysis demonstrated that the patient had compound heterozygous mutations in the cysteine-rich loop (A1017T and Y1088C) of the NPC1 gene. To our knowledge there has been no previous report of the A1017T mutation. The pathological features of this patient support the notion that NPC has an aspect of α-synucleinopathy, and long-term survivors of NPC may develop a frontotemporal-predominant distribution of brain atrophy.


Assuntos
Doença de Niemann-Pick Tipo C/patologia , Adulto , Tronco Encefálico/patologia , Proteínas de Transporte/genética , Córtex Cerebral/patologia , Lobo Frontal/patologia , Humanos , Peptídeos e Proteínas de Sinalização Intracelular , Corpos de Lewy/patologia , Masculino , Glicoproteínas de Membrana/genética , Mutação , Emaranhados Neurofibrilares/patologia , Proteína C1 de Niemann-Pick , Doença de Niemann-Pick Tipo C/diagnóstico , Doença de Niemann-Pick Tipo C/genética , Lobo Temporal/patologia
2.
Pediatr Int ; 53(6): 858-66, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21429057

RESUMO

BACKGROUND: Owing to advances in neonatal intensive care, many infants who are hospitalized in neonatal intensive care units (NICU) can survive and grow, and are referred to as NICU survivors. However, social development in NICU survivors has not been fully explored. METHODS: To examine the social development of NICU survivors, a questionnaire consisting of the Modified Checklist for Autism in Toddlers (M-CHAT) was used. The M-CHAT was completed by the parents of either NICU survivors (n= 117) or normally delivered children (control group, n= 112) during their regular medical checkups at a corrected age of 12 months. RESULTS: Ninety percent of NICU survivors and 63% of control children did not pass the M-CHAT screen. As it was originally designed for children aged 18-30 months, failed M-CHAT items could have been due to developmental issues and not due to autistic spectrum disorders. However, there was a significant difference in the total number of items failed between the two groups. In particular, many NICU survivors did not pass on M-CHAT items, such as oversensitivity to noise, unusual finger movements, and attempts to attract attention. Concerning perinatal complications, infants with low birthweight and/or the need for respiratory support tended to have a higher number of failures on all M-CHAT items. CONCLUSIONS: NICU survivors may have distinct developmental patterns of social communication, and should be followed up for assessment of social skills and neurological development.


Assuntos
Unidades de Terapia Intensiva Neonatal , Programas de Rastreamento , Comportamento Social , Sobreviventes/estatística & dados numéricos , Transtorno Autístico/epidemiologia , Transtorno Autístico/psicologia , Pré-Escolar , Estudos Transversais , Feminino , Seguimentos , Humanos , Lactente , Japão/epidemiologia , Masculino , Estudos Retrospectivos , Fatores de Risco , Inquéritos e Questionários , Fatores de Tempo
3.
J Am Soc Nephrol ; 19(9): 1701-11, 2008 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-18525005

RESUMO

Recently, endothelial dysfunction induced by an uncoupling of vascular endothelial growth factor (VEGF) and nitric oxide has been implicated in the pathogenesis of diabetic nephropathy (DN). Investigating the pathogenesis of DN has been limited, however, because of the lack of animal models that mimic the human disease. In this report, pancreatic beta cell-specific calmodulin-overexpressing transgenic (CaMTg) mice, a potential new model of DN, are characterized with particular emphasis on VEGF and related molecules. CaMTg mice developed hyperglycemia at 3 wk and persistent proteinuria by 3 mo. Morphometric analysis showed considerable increases in the glomerular and mesangial areas with deposition of type IV collagen. Moreover, the pathologic hallmarks of human DN (mesangiolysis, Kimmelstiel-Wilson-like nodular lesions, exudative lesions, and hyalinosis of afferent and efferent arteries with neovascularization) were observed. In addition, increased VEGF expression was associated with an increased number of peritubular capillaries. Expression of endothelial nitric oxidase synthase was reduced and that of VEGF was markedly elevated in CaMTg mice kidney compared with nontransgenic mice. No differences in VEGF receptor-1 or VEGF receptor-2 expression were observed between CaMTg mice and nontransgenic kidneys. In summary, CaMTg mice develop most of the distinguishing lesions of human DN, and the elevated VEGF expression in the setting of diminished endothelial nitric oxide synthase expression may lead to endothelial proliferation and dysfunction. This model may prove useful in the study of the pathogenesis and treatment of DN.


Assuntos
Calmodulina/metabolismo , Nefropatias Diabéticas/patologia , Modelos Animais de Doenças , Células Secretoras de Insulina/metabolismo , Rim/patologia , Animais , Arteríolas/patologia , Capilares/metabolismo , Nefropatias Diabéticas/sangue , Nefropatias Diabéticas/urina , Feminino , Imuno-Histoquímica , Rim/irrigação sanguínea , Rim/metabolismo , Camundongos , Camundongos Transgênicos , Óxido Nítrico Sintase Tipo III/metabolismo , Receptores de Fatores de Crescimento do Endotélio Vascular/metabolismo , Trombomodulina/metabolismo , Fator A de Crescimento do Endotélio Vascular/metabolismo
4.
Int J Dev Neurosci ; 25(6): 367-72, 2007 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-17804189

RESUMO

Accumulating evidence suggests the possible association between the concentrations of serum brain-derived neurotrophic factor (BDNF) and psychiatric disease with impaired brain development. Yet the reasons remain unclear. We therefore investigated the characteristics of serum BDNF as well as its age-related changes in healthy controls in comparison to autism cases. BDNF was gradually released from platelets at 4 degrees C, reached a maximal concentration after around 24 h, and remained stable until 42 h. At room temperature, BDNF was found to be immediately degraded. Circadian changes, but not seasonal changes, were found in serum levels of BDNF existing as the mature form with a molecular mass of 14 kDa. In healthy controls, the serum BDNF concentration increased over the first several years, then slightly decreased after reaching the adult level. There were no sex differences between males and females. In the autism cases, mean levels were significantly lower in children 0-9 years old compared to teenagers or adults, or to age-matched healthy controls, indicating a delayed BDNF increase with development. In a separate study of adult rats, a circadian change in serum BDNF was found to be similar to that in the cortex, indicating a possible association with cortical functions.


Assuntos
Envelhecimento/sangue , Transtorno Autístico/sangue , Fator Neurotrófico Derivado do Encéfalo/sangue , Encéfalo/crescimento & desenvolvimento , Encéfalo/metabolismo , Adolescente , Adulto , Distribuição por Idade , Animais , Transtorno Autístico/fisiopatologia , Plaquetas/metabolismo , Encéfalo/fisiopatologia , Fator Neurotrófico Derivado do Encéfalo/química , Córtex Cerebral/crescimento & desenvolvimento , Córtex Cerebral/metabolismo , Córtex Cerebral/fisiopatologia , Criança , Pré-Escolar , Ritmo Circadiano/fisiologia , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Pessoa de Meia-Idade , Peso Molecular , Ratos , Estações do Ano , Distribuição por Sexo , Manejo de Espécimes , Temperatura , Fatores de Tempo , Regulação para Cima/fisiologia
5.
Am J Intellect Dev Disabil ; 114(4): 225-36, 2009 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-19642712

RESUMO

Our aim was to identify risk factors for falling and establish a method to assess risk for falls in adults with intellectual disabilities. In a cross-sectional survey of 144 Japanese adults, we found that age, presence of epilepsy, and presence of paretic conditions were independent risk factors. The Tinetti balance and gait instrument was successfully administered to this population and resulted in high diagnostic accuracy (sensitivity 88.9%, specificity 91.9%) for identifying individuals at risk when the cutoff score was set at 25. Participants whose balance and gait deteriorated showed a decrease in the Tinetti score of at least 2 points per year. Thus, the Tinetti instrument may be an effective tool to detect an increased risk of fall in this population.


Assuntos
Acidentes por Quedas/estatística & dados numéricos , Deficiência Intelectual/epidemiologia , Adulto , Idoso , Comorbidade , Estudos Transversais , Epilepsia/complicações , Epilepsia/epidemiologia , Feminino , Transtornos Neurológicos da Marcha/complicações , Transtornos Neurológicos da Marcha/epidemiologia , Humanos , Deficiência Intelectual/complicações , Deficiência Intelectual/tratamento farmacológico , Japão , Masculino , Pessoa de Meia-Idade , Exame Neurológico , Paralisia/complicações , Paralisia/epidemiologia , Equilíbrio Postural , Psicotrópicos/efeitos adversos , Psicotrópicos/uso terapêutico , Medição de Risco
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA